scholarly journals Effect of intravitreal dexamethasone implant (0.7mg) on intraocular pressure when used for macular edema in real world clinical practice

2016 ◽  
Vol 4 (10) ◽  
pp. 1750-1755
Author(s):  
Dr. Elfride F. Sanjana ◽  
◽  
Dr Sujatha Mohan ◽  
Dr Ravichandran Kandaswamy ◽  
◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Clinical Practice ◽  
Macular Edema ◽  
Real World ◽  
Dexamethasone Implant ◽  
Intravitreal Dexamethasone Implant ◽  
Intravitreal Dexamethasone

scholarly journals Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world

PLoS ONE ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. e0209997 ◽  
Author(s):  
Javier Zarranz-Ventura ◽  
Anna Sala-Puigdollers ◽  
Daniel Velazquez-Villoria ◽  
Marc Figueras-Roca ◽  
Sergio Copete ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Real World ◽  
Dexamethasone Implant ◽  
The Real ◽  
Pressure Elevation ◽  
Intravitreal Dexamethasone Implant ◽  
Intraocular Pressure Elevation ◽  
Intravitreal Dexamethasone

Cauterization of Ozurdex wound for the prevention of scleral leakage in vitrectomized eyes

2017 ◽  
Vol 28 (3) ◽  
pp. 341-343 ◽  
Author(s):  
Claudio Furino ◽  
Nicola Recchimurzo ◽  
Francesco Boscia ◽  
Giovanni Alessio
Keyword(s):  
Intraocular Pressure ◽  
Injection Site ◽  
Macular Edema ◽  
Operating Room ◽  
Wound Closure ◽  
Dexamethasone Implant ◽  
Intravitreal Dexamethasone Implant ◽  
Intravitreal Dexamethasone ◽  
The University ◽  
Eye Clinic

Purpose: To study if cauterization of the scleroconjuctival wound secondary to intravitreal dexamethasone implant in vitrectomized eyes is effective to avoid scleral leakage and hypotony. Methods: A total of 35 vitrectomized eyes of 35 consecutive patients with macular edema who underwent a single intravitreal dexamethasone implant injection in the operating room at the Eye Clinic of the University of Bari, Italy, from 2013 to 2017 were retrospectively reviewed. At the end of the injection, transconjuctival/scleral bipolar cauterization was applied at the injection site and the presence or absence of leakage or hypotony was studied. Results: At the end of the procedure, no patient showed fluid leakage from the cauterized scleroconjuctival wound. No ocular hypotony of other ophthalmic complications were observed at 1 hour and 1 day from injection and intraocular pressure did not change significantly from baseline at 1 hour and 1 day after injection. Conclusions: Cauterization of the scleral wound after intravitreal dexamethasone implant injection in vitrectomized eyes is safe and effective to avoid scleral leakage with secondary hypotony, obtaining a watertight wound closure.

scholarly journals Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study

2015 ◽  
pp. 1255 ◽  
Author(s):  
Darryl Baptiste ◽  
Wai-Ching Lam ◽  
David Albiani ◽  
Pradeepa Yoganathan ◽  
John Chanchiang Chen ◽  
...  
Keyword(s):  
Macular Edema ◽  
Real World ◽  
Dexamethasone Implant ◽  
Intravitreal Dexamethasone Implant ◽  
Intravitreal Dexamethasone

Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience

2018 ◽  
Vol 241 (1) ◽  
pp. 9-16 ◽  
Author(s):  
Paulo Mello Filho ◽  
Gabriel Andrade ◽  
Andre Maia ◽  
Mauricio Maia ◽  
Laurentino Biccas Neto ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Real World ◽  
Dexamethasone Implant ◽  
Intravitreal Dexamethasone Implant ◽  
Intravitreal Dexamethasone

Intravitreal Dexamethasone Implant for Cystoid Macular Edema and Inflammation after Scleral Buckling

2015 ◽  
Vol 25 (5) ◽  
pp. e98-e100 ◽  
Author(s):  
Vincenza Bonfiglio ◽  
Matteo R. Fallico ◽  
Andrea Russo ◽  
Vittorio De Grande ◽  
Antonio Longo ◽  
...  
Keyword(s):  
Macular Edema ◽  
Cystoid Macular Edema ◽  
Scleral Buckling ◽  
Dexamethasone Implant ◽  
Intravitreal Dexamethasone Implant ◽  
Intravitreal Dexamethasone
Sign in / Sign up

Export Citation Format

Share Document